Noven's history began in 1987 in Miami, Florida with the mission to develop differentiated prescription transdermal drug delivery systems (patches) to benefit patients across a range of therapeutic conditions. Today, Noven is the U.S. platform for Hisamitsu, the world's largest patch manufacturer, with fully-integrated R&D, clinical, manufacturing, and sales functions offering prescription products in the areas of women's health and central nervous system (CNS) disorders.
Specialty pharmaceutical company engaged in the research, development, manufacture, marketing and sale of prescription pharmaceutical products.
Year of Incorporation:
Chief Executive Officer:
Media, General Business
& Other Inquiries:
Partnering and Other Business Development Opportunities
Sunshine Act Inquiries:
Manager – Recruiting
Community Support:Corporate Social Responsibility
Noven is a wholly-owned subsidiary of Hisamitsu Pharmaceutical Co., Inc. – bringing the benefits of patch therapy to patients around the world.